Literature DB >> 14618016

Overview of prevention and intervention trials for type 1 diabetes.

Jorge Daaboul1, Desmond Schatz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14618016     DOI： 10.1023/a:1027308310837

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  40 in total

1.  Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group.

Authors:  M Karvonen; M Viik-Kajander; E Moltchanova; I Libman; R LaPorte; J Tuomilehto
Journal:  Diabetes Care       Date:  2000-10       Impact factor: 19.112

2.  Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines.

Authors:  M Polanski; N S Melican; J Zhang; H L Weiner
Journal:  J Autoimmun       Date:  1997-08       Impact factor: 7.094

3.  Effects of insulin in relatives of patients with type 1 diabetes mellitus.

Authors: 
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

4.  Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.

Authors:  J Silverstein; N Maclaren; W Riley; R Spillar; D Radjenovic; S Johnson
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

5.  Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice.

Authors:  W L Baeder; J Sredy; S N Sehgal; J Y Chang; L M Adams
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

6.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

7.  Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children.

Authors:  J C Carel; C Boitard; G Eisenbarth; J F Bach; P F Bougnères
Journal:  J Autoimmun       Date:  1996-12       Impact factor: 7.094

8.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

9.  Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes.

Authors:  D B Jones; N R Hunter; G W Duff
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

10.  Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

Authors:  J Tian; M A Atkinson; M Clare-Salzler; A Herschenfeld; T Forsthuber; P V Lehmann; D L Kaufman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307
View more
  11 in total

1.  Clinical intraocular islet transplantation is not a number issue.

Authors:  A Shishido; A Caicedo; R Rodriguez-Diaz; A Pileggi; P-O Berggren; M H Abdulreda
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2016-07-26

2.  Increased galectin-1 expression in muscle of Astragalus polysaccharide-treated Type 1 diabetic mice.

Authors:  Xingjian Zhou; Yancheng Xu; Guoming Yang; Fang Li
Journal:  J Nat Med       Date:  2011-03-20       Impact factor: 2.343

3.  Suppression of autoimmune diabetes by soluble galectin-1.

Authors:  Marcelo J Perone; Suzanne Bertera; William J Shufesky; Sherrie J Divito; Angela Montecalvo; Alicia R Mathers; Adriana T Larregina; Mabel Pang; Nilufer Seth; Kai W Wucherpfennig; Massimo Trucco; Linda G Baum; Adrian E Morelli
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Prevention of type 1 diabetes by gene therapy.

Authors:  Chaorui Tian; Jessamyn Bagley; Nathalie Cretin; Nilufer Seth; Kai W Wucherpfennig; John Iacomini
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 5.  Understanding immunology via engineering design: the role of mathematical prototyping.

Authors:  David J Klinke; Qing Wang
Journal:  Comput Math Methods Med       Date:  2012-09-03       Impact factor: 2.238

6.  Age-corrected beta cell mass following onset of type 1 diabetes mellitus correlates with plasma C-peptide in humans.

Authors:  David J Klinke
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

7.  Immune Checkpoint Inhibitor-Associated Type 1 Diabetes Mellitus: Case Series, Review of the Literature, and Optimal Management.

Authors:  Jonathan Kapke; Zachary Shaheen; Deepak Kilari; Paul Knudson; Stuart Wong
Journal:  Case Rep Oncol       Date:  2017-10-17

8.  Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus.

Authors:  David J Klinke
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

9.  Prevention or early cure of type 1 diabetes by intranasal administration of gliadin in NOD mice.

Authors:  David P Funda; Petra Fundova; Axel Kornerup Hansen; Karsten Buschard
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

10.  Pathogenesis of Type 1 Diabetes Mellitus and Rodent Experimental Models.

Authors:  I G Gvazava; O S Rogovaya; M A Borisov; E A Vorotelyak; A V Vasiliev
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.